May 20, 2013
In a much-tweeted cover story for the New York Times Magazine, Peggy Orenstein recently wrote that she once believed a mammogram saved her life. Sixteen years later, after dealing with breast cancer round two, she says she now wonders whether that first mammogram mattered at all. “Would . . . → Read More: The Mammography Debate: To Screen or Not to Screen?
Angelina Jolie’s op-ed in The New York Times was big news. Jolie shared her family history of cancer, her own genetic mutation, and her choice to have prophylactic surgery– agonizing decisions faced by other high risk women.
Actress Angelina Jolie leaves Lancaster House after attending the G8 Foreign Ministers’ conference on April 11, . . . → Read More: Celebrity Breasts and Corporate Gene Patents
Barbara Brenner (1951-2013)
Barbara Brenner was 41 when she was first diagnosed with breast cancer, a diagnosis that led the lawyer and activist to join the board of Breast Cancer Action, a grassroots advocacy organization in San Francisco started by women with breast cancer. A year later, she became the organization’s first full-time executive director. . . . → Read More: In Honor and Memory of Barbara Brenner
I’ve been spending much of my time working with the Breast Cancer Consortium to develop plans, projects, and analyses. One of my roles is to edit the Quarterly newsletter, which has just been released.
Table of Contents The Breast Cancer Consortium, Gathering Momentum! “Our Feel-Good War on Breast Cancer” Patients, Patents, and Profits “Cancer . . . → Read More: Breast Cancer Consortium Quarterly, Second Issue
Peggy Orenstein’s April 25, 2013 article–the cover story for this Week’ s New York Times’ Magazine, offers an in-depth look at breast cancer in the United States. The 9-page essay– called “Our Feel-Good War on Breast Cancer” — is well worth the read, highlighting key issues in breast cancer awareness campaigns, . . . → Read More: “Our Feel-Good War on Breast Cancer”
When the Human Genome Project started in 1990 there were fewer than 100 genes associated with human diseases. The first genetic mutation (for Huntington’s disease) was identified in 1986, just a few years before the Project started. After more than a decade of technological innovation and about $3.8 billion, a team of scientists across more than forty research sites succeeded . . . → Read More: Patients, Patents, and Profits in a Genomic Age
I get public relations pitches every day about the latest breast cancer fill-in-the-blank. I usually delete them as soon as they come in, but last week I lingered on one longer than usual. The pitch said that Dr. Allen Gabriel and The Pink Lemonade Project, along with Alaska Airlines and Starbucks, were inviting me . . . → Read More: Rights or Rhetoric? Breast reconstruction and the yet-to-be-tapped market of breast cancer survivors
A few weeks ago Tera Warner interviewed me for the Women’s International Summit for Health (WISH) – a FREE series of interviews and writings on a range of topics from breast cancer to sex and hormones to money, love, mystery, and the secrets of women’s self-defense. Tera asked me about the history of the pink ribbon, what’s . . . → Read More: Here’s my interview on WISH
In celebration of International Women’s Day, the Women’s International Summit for Health (WISH) kicks off tomorrow (March 8th). In its fourth and final year, the 2013 WISH summit features interviews and writings from leading experts on breast cancer, sex and hormones, diet and detox, love and luck, money, mystery, mothering and even the secrets of women’s self-defense. . . . → Read More: International Women’s Day, and the WISH Summit
My last visit with Rachel. November, 2011.
It was a year ago today that Rachel Cheetham Moro died. Those who love her, and are inspired by her, continue to absorb this reality and try to keep on keeping on. It’s not easy.
I’ve written a fair amount about Rachel in the last year to . . . → Read More: Remembrances